Dr. Reddy's Laboratories Ltd has announced the audit of its API manufacturing plant 2 at Bollaram, Hyderabad. The company has received the Establishment Inspection Report (EIR) from US FDA, for the above-referred facility, indicating closure of the audit and the inspection classification of this facility is determined as Voluntary Action Initiated (VAI).
Shares of DR.REDDY'S LABORATORIES LTD. was last trading in BSE at Rs.2610.05 as compared to the previous close of Rs. 2677.1. The total number of shares traded during the day was 17599 in over 1622 trades.
The stock hit an intraday high of Rs. 2687 and intraday low of 2610.05. The net turnover during the day was Rs. 46459146.